CeriBell, Inc Cash Flow Conversion Efficiency
CeriBell, Inc cash flow conversion efficiency. Based on the latest financial reports, CeriBell, Inc (CBLL) has a cash flow conversion efficiency ratio of -0.100x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.86 Million) by net assets ($128.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of CeriBell, Inc (2022–2025)
Cash flow conversion efficiency of CeriBell, Inc from 2022 to 2025. This chart illustrates how CeriBell, Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CeriBell, Inc stock price for real-time trading data and today's change.
CeriBell, Inc Cash Flow Conversion Ratio Explained
CeriBell, Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
CeriBell, Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CeriBell, Inc ranked by their cash flow conversion efficiency. Also see CBLL market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Generation Development Group Ltd
AU:GDG
|
0.037x |
|
Hitevision Co Ltd
SHE:002955
|
0.131x |
|
Mivtach Shamir
TA:MISH
|
-0.050x |
|
SK ETERNIX CO LT
KO:475150
|
0.497x |
|
Bafang Electric Suzhou Co Ltd
SHG:603489
|
0.017x |
|
Jiangsu Asia Pacific Light Alloy Technology Co Ltd
SHE:002540
|
-0.018x |
|
Madhya Bharat Agro Products Limited
NSE:MBAPL
|
0.205x |
|
Scope Metals Group Ltd
TA:SCOP
|
0.031x |
Annual Cash Flow Conversion Efficiency for CeriBell, Inc (2022–2025)
The table below shows the annual cash flow conversion efficiency of CeriBell, Inc from 2022 to 2025. Review CeriBell, Inc (CBLL) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $155.34 Million | $-40.81 Million | -0.263x | -43.31% |
| 2024-12-31 | $191.16 Million | $-35.04 Million | -0.183x | -170.57% |
| 2023-12-31 | $-112.25 Million | $-29.16 Million | 0.260x | -29.87% |
| 2022-12-31 | $-86.40 Million | $-32.00 Million | 0.370x | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more